US 9,883,315

Application 15/250,870 · Granted Jan 30, 2018

Systems and methods for calibrating speakers

Estimated expiration

February 21, 2033

6y 93d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Feb 21, 2013
+ 20 years
Feb 21, 2033
PTA +0d
Feb 21, 2033
No TD
—
Final
Feb 21, 2033

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
August 29, 2016
Earliest effective filing
February 21, 2013
Issue date
January 30, 2018
PTA
0 days
Base expiry (before PTA)
February 21, 2033

February 21, 2013 + 20 years = February 21, 2033

  • Continuation of application 13/773,483, filed Feb 21, 2013, issued as US 9,438,996
  • PRO61/601,529 — Provisional — not used for base term
  • PRO61/601,529 — Provisional — not used for base term

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 15/250,870 · US 9,883,315

PatentReply compiles the prosecution history behind US 9,883,315: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US9883315

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.